ATH 33.3% 0.4¢ alterity therapeutics limited

kempler on abc tonight on the business , page-14

  1. 221 Posts.
    lightbulb Created with Sketch. 90
    Hi Skint
    If there were problems with the design of the Imagine Trial and statistical significance was going to be difficult to show then Ticky Fullarton's question to Kempler about hosing down expectations, particularly in regard to cognition, prior to the result was a valid one.
    Cheers
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.